CASI Pharmaceuticals CASIF
OTC CASIF
$0.10 +0.00 (+0.05%)
As of: Oct 21, 2026 · 10:56 AM EDT

CASI Pharmaceuticals (CASIF) Work In Process (2025)

Updated

CASI Pharmaceuticals (CASIF) posted Work In Process of $504,000 for Q4 2025.

Analysis

CASI Pharmaceuticals (CASIF) Work In Process (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 CASI Pharmaceuticals 1.86 Mn -18.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 504,000.00
API Access

CASI Pharmaceuticals Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=CASIF&period=max&api_key=YOUR_API_KEY